Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Kamada (KMDA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Kamada's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.140 -0.040    -0.77%
11:22:16 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 5,396
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 5.110 - 5.150
Kamada 5.140 -0.040 -0.77%

Kamada Ltd Company Profile

 
Get an in-depth profile of Kamada, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

378

Equity Type

ORD

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.

Contact Information

Address 2 Holzman Street Science Park
PO Box 4081 Rehovot, 7670402
Israel
Phone 972 8 940 6472
Fax 972 8 940 6473

Top Executives

Name Age Since Title
Lilach Asher-Topilsky 51 2019 Independent Chairman of the Board
David Tsur 74 1990 Co-Founder & Independent Deputy Chairman of the Board
Leon Y. Recanati 76 2005 Independent Director
Karnit Goldwasser 47 2019 Independent Director
Ishay Davidi 62 2019 Independent Director
Benjamin Dekel 57 2023 Independent External Director
Assaf Itshayek 51 2023 Independent External Director
Lilach Payorski 50 2021 Independent Director
Uri Botzer 34 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KMDA Comments

Write your thoughts about Kamada Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Adam Smith
Adam Smith Jan 08, 2021 12:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MERCATOR  WA [MRCP] The leader in Europe with no debt and with ridiculous low PE about 4 after Q4 2020 report
Omer Livnat
Omer Livnat Oct 23, 2020 3:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA APPROVAL SEASON: COVID-19 VERSION LIMITED ESITIONAfter Gilead’s approval, Surely there’ll be a wave of approvals in the vaccine related companies.
Lost BA
Lost BA Sep 30, 2020 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There we go!
Lost BA
Lost BA Sep 09, 2020 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There are very big hopes here, treatment for Covid already working! question of time for 300% up!
Shon Cash
Shon Cash Sep 09, 2020 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Go home to sleep
EL KAT
EL KAT Aug 27, 2020 3:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down, down, down
EL KAT
EL KAT Aug 26, 2020 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
all over the world, shares will be falling
Florin Tudor
Florin Tudor Aug 23, 2020 6:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
boom tomorrow to the moon's 100$!!
Mohammad Alazzah
Mohammad Alazzah Aug 23, 2020 6:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I saw the news but is it going to happen for sure? Are you experienced?
Rambi Zambi
Rambi2019 Aug 23, 2020 6:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mohammad Alazzah  sell on news
Mohammad Alazzah
Mohammad Alazzah Aug 23, 2020 6:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy thr rumor and sell the news makes sense. Thanks
ruben mansh
ruben mansh Aug 14, 2020 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
daytrippers cause revenue harvest now but Kamd has stronger future
Guy Rodman
Guy Rodman Jun 29, 2020 3:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is it falling?
Shon Cash
Shon Cash Jun 29, 2020 3:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One person was dead after treatment, but reason of the death not approved yet.
will wonks
will wonks Mar 19, 2020 12:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They should be releasing a test soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email